Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (67) 67
infectious diseases (66) 66
male (59) 59
index medicus (58) 58
female (52) 52
middle aged (50) 50
adult (49) 49
hiv infections - drug therapy (46) 46
hiv (42) 42
virology (32) 32
immunology (31) 31
life sciences (30) 30
human immunodeficiency virus--hiv (28) 28
viral load (25) 25
hiv infections - virology (24) 24
aids (23) 23
anti-hiv agents - therapeutic use (23) 23
antiretroviral therapy (22) 22
microbiology (21) 21
hiv infection (19) 19
therapy (19) 19
cd4 lymphocyte count (18) 18
aids/hiv (17) 17
antiretroviral drugs (17) 17
hiv infections - complications (17) 17
pharmacology & pharmacy (17) 17
protease inhibitors (17) 17
treatment outcome (17) 17
risk factors (16) 16
acquired immune deficiency syndrome--aids (15) 15
active antiretroviral therapy (15) 15
drug therapy (15) 15
health aspects (15) 15
virus diseases (15) 15
santé publique et épidémiologie (14) 14
acquired immune deficiency syndrome (13) 13
aged (13) 13
antiretroviral therapy, highly active (13) 13
antiviral agents (13) 13
drug therapy, combination (13) 13
hiv infections - immunology (13) 13
human health and pathology (13) 13
human immunodeficiency virus (13) 13
cohort studies (12) 12
drug administration schedule (12) 12
hiv-1 - drug effects (12) 12
infection (12) 12
mortality (12) 12
patients (12) 12
prospective studies (12) 12
safety (12) 12
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (11) 11
france - epidemiology (11) 11
hepatitis c (11) 11
hiv patients (11) 11
research article (11) 11
reverse transcriptase inhibitors - therapeutic use (11) 11
rna, viral - blood (11) 11
viruses (11) 11
[sdv.mhep.mi]life sciences [q-bio]/human health and pathology/infectious diseases (10) 10
cohort (10) 10
hepatitis (10) 10
hiv-1 (10) 10
hiv-1-infected patients (10) 10
human-immunodeficiency-virus (10) 10
infected patients (10) 10
multidisciplinary sciences (10) 10
population (10) 10
risk (10) 10
antiretroviral agents (9) 9
france (9) 9
hepatitis c virus (9) 9
hiv infections - epidemiology (9) 9
hiv-1 - isolation & purification (9) 9
hiv-infected patients (9) 9
infections (9) 9
medicine (9) 9
science (9) 9
analysis (8) 8
anti-hiv agents - administration & dosage (8) 8
care and treatment (8) 8
disease (8) 8
pharmacokinetics (8) 8
pharmacology (8) 8
cd4 antigen (7) 7
coinfection (7) 7
efficacy (7) 7
hiv-1 - genetics (7) 7
hiv-1 - physiology (7) 7
individuals (7) 7
plasma (7) 7
research (7) 7
tenofovir (7) 7
young adult (7) 7
antiretroviral therapy, highly active - methods (6) 6
biology and life sciences (6) 6
coinfection - drug therapy (6) 6
comorbidity (6) 6
drug resistance, viral (6) 6
epidemiology (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Incidence of HIV-Related Anal Cancer Remains Increased Despite Long-Term Combined Antiretroviral Treatment: Results From the French Hospital Database on HIV
by Christophe Piketty and Hana Selinger-Leneman and Anne-Marie Bouvier and Aurelien Belot and Murielle Mary-Krause and Claudine Duvivier and Manuela Bonmarchand and Laurent Abramowitz and Dominique Costagliola and Sophie Grabar
Journal of Clinical Oncology, ISSN 0732-183X, 12/2012, Volume 30, Issue 35, pp. 4360 - 4366
Purpose To study recent trends in the incidence of anal cancer in HIV-infected patients receiving long-term combined antiretroviral treatment (cART) compared... 
UNITED-STATES | THERAPY | ONCOLOGY | IMMUNE-RESPONSES | RISK | AIDS | INFECTION | HUMAN-IMMUNODEFICIENCY-VIRUS | INTRAEPITHELIAL NEOPLASIA | POSITIVE MEN | HAART | France - epidemiology | Carcinoma, Squamous Cell - epidemiology | Carcinoma, Squamous Cell - virology | HIV Infections - epidemiology | Humans | Middle Aged | Anus Neoplasms - virology | Male | Incidence | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Anus Neoplasms - epidemiology | Antiretroviral Therapy, Highly Active - methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text [gamma][delta] T-cell subsets in HIV controllers: potential role of T[gamma][delta]17 cells in the regulation of chronic immune activation
by Chevalier, Mathieu F and Bhatnagar, Nupur and Didier, Celine and Lopez-Gonzalez, Moises and Pavie, Juliette and Bollens, Diane and Duvivier, Claudine
AIDS, ISSN 0269-9370, 07/2019, Volume 33, Issue 8, p. 1283
Antiviral agents | Medical research | Care and treatment | Usage | Medicine, Experimental | Research | T cells | HIV infection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Factors Associated With Virological Failure in HIV-1-Infected Patients Receiving Darunavir/Ritonavir Monotherapy
by Sidonie Lambert-Niclot and Philippe Flandre and Marc-Antoine Valentin and Gilles Peytavin and Claudine Duvivier and Stephanie Haim-Boukobza and Michele Algarte-Genin and Yazdan Yazdanpanah and Pierre-Marie Girard and Christine Katlama and Vincent Calvez and Anne-Genevieve Marcelin
The Journal of Infectious Diseases, ISSN 0022-1899, 10/2011, Volume 204, Issue 8, pp. 1211 - 1216
Background. Our objective was to determine virological and clinical characteristics associated with virological failure in human immunodeficiency virus... 
HIV/AIDS | Antiretrovirals | Highly active antiretroviral therapy | RNA | HIV | Viremia | DNA | Experimentation | Virology | HIV 1 | Blood plasma | INFECTIOUS DISEASES | MONARK TRIAL | LOPINAVIR/RITONAVIR MONOTHERAPY | MICROBIOLOGY | ANTIRETROVIRAL THERAPY | IMMUNOLOGY | PCR | Darunavir | Ritonavir - administration & dosage | HIV Infections - virology | Humans | Middle Aged | Logistic Models | Male | RNA, Viral - blood | HIV Protease Inhibitors - administration & dosage | HIV-1 - genetics | Viral Load | HIV-1 - physiology | Adult | Female | HIV Infections - drug therapy | Patient Compliance | Sulfonamides - administration & dosage | Ritonavir | Viruses | Dosage and administration | Research | Drug therapy | Inactivation | HIV infection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large French multicenter cohort study
by Cotte, Laurent and Ferry, Tristan and Pugliese, Pascal and Valantin, Marc-Antoine and Allavena, Clotilde and Cabiea, Andre and Poizot-Martin, Isabelle and Rey, David and Duvivier, Claudine and Cheret, Antoine and Dellamonica, Pierre and Pradat, Pierre and Parienti, Jean-Jacques and Dat'AIDS Study Grp and Dat’AIDS study group
PLoS ONE, ISSN 1932-6203, 02/2017, Volume 12, Issue 2, p. e0170661
Objectives Pill burden during antiretroviral treatment (ART) is associated with worse adherence and impaired virological suppression. We compared the... 
METAANALYSIS | MULTIDISCIPLINARY SCIENCES | EMTRICITABINE | RESISTANCE | FIXED-DOSE COMBINATION | EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | QUALITY-OF-LIFE | PILL BURDEN | ADHERENCE | TENOFOVIR | HIV-INFECTED PATIENTS | Anti-HIV Agents - administration & dosage | Antiretroviral Therapy, Highly Active | Drug Administration Schedule | HIV-1 - drug effects | Humans | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Male | Retrospective Studies | France | Antiviral agents | Care and treatment | HIV infection | Analysis | Risk factors | Virology | Short tandem repeats | Antiretroviral drugs | Therapy | Simplification | Infections | Risk analysis | Patients | Success | Antiretroviral therapy | Studies | Infectious diseases | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Risk management | Drug therapy | Life Sciences | Santé publique et épidémiologie | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Impact of Antiretroviral Drugs on Fracture Risk in HIV-Infected Individuals: A Case–Control Study Nested Within the French Hospital Database on HIV (FHDH-ANRS CO4)
by Costagliola, Dominique and Potard, Valérie and Lang, Sylvie and Abgrall, Sophie and Duvivier, Claudine and Fischer, Hugues and Joly, Véronique and Lacombe, Jean-Marc and Valantin, Marc-Antoine and Mary-Krause, Murielle and Rozenberg, Sylvie and FHDH ANRS CO4
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 02/2019, Volume 80, Issue 2, pp. 214 - 223
BACKGROUND:HIV-infected patients have lower bone mineral density and a higher incidence of fractures than the general population of the same age and sex. To... 
POPULATION | INFECTIOUS DISEASES | ABACAVIR-LAMIVUDINE | TURNOVER | BONE-MINERAL DENSITY | tenofovir | EMTRICITABINE | PREVALENCE | IMMUNOLOGY | fracture | bone mineral density | THERAPY | PREDICTORS | protease inhibitors | antiretroviral drugs | COHORT | Drugs | Sexually transmitted diseases--STD | RNA-directed DNA polymerase | Glucocorticoids | Control methods | Sex | Tenofovir | Osteoporosis | Body mass index | Regression models | Biomedical materials | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Biocompatibility | Diagnosis | Health risks | Proteinase inhibitors | Exposure | Regression analysis | Risk analysis | Patients | Fractures | Protease inhibitors | Body mass | Body size | Alcoholic beverages | Bone mineral density | Health risk assessment | Smoking | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Pharmacology | Infectious diseases | Pharmaceutical sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010
by Loko, Marc-Arthur and Salmon, Dominique and Carrieri, Patrizia and Winnock, Maria and Mora, Marion and Merchadou, Laurence and Gillet, Stéphanie and Pambrun, Elodie and Delaune, Jean and Valantin, Marc-Antoine and Poizot-Martin, Isabelle and Neau, Didier and Bonnard, Philippe and Rosenthal, Eric and Barange, Karl and Morlat, Philippe and Lacombe, Karine and Gervais, Anne and Rouges, François and See, Alain B and Lascoux-Combe, Caroline and Vittecoq, Daniel and Goujard, Cécile and Duvivier, Claudine and Spire, Bruno and Izopet, Jacques and Sogni, Philippe and Serfaty, Lawrence and Benhamou, Yves and Bani-Sadr, Firouzé and Dabis, François and ANRS CO 13 HEPAVIH Study Grp and ANRS CO 13 HEPAVIH Study Group and for the ANRS CO 13 HEPAVIH Study Group
BMC Infectious Diseases, ISSN 1471-2334, 10/2010, Volume 10, Issue 1, pp. 303 - 303
Background: In France, it is estimated that 24% of HIV-infected patients are also infected with HCV. Longitudinal studies addressing clinical and public health... 
TRANSIENT ELASTOGRAPHY | DRUG-USERS | INFECTIOUS DISEASES | REAL-LIFE | CHRONIC HEPATITIS-C | ACTIVE ANTIRETROVIRAL THERAPY | LIVER FIBROSIS | ALPHA-2A PLUS RIBAVIRIN | HUMAN-IMMUNODEFICIENCY-VIRUS | CLINICAL PROGRESSION | MORTALITE 2005 | Carcinoma, Hepatocellular - epidemiology | Hepatitis C, Chronic - pathology | HIV Infections - epidemiology | Humans | Middle Aged | Male | RNA, Viral - blood | Hepatitis C, Chronic - complications | Viral Load | Liver Neoplasms - epidemiology | HIV Infections - pathology | HIV-1 - isolation & purification | Adult | Anti-HIV Agents - therapeutic use | Female | Surveys and Questionnaires | Hepatitis C, Chronic - epidemiology | Hepacivirus - isolation & purification | France - epidemiology | Risk Factors | CD4 Lymphocyte Count | Hepatitis C, Chronic - drug therapy | Disease Progression | Antiretroviral Therapy, Highly Active | Medication Adherence | HIV Infections - complications | HIV Infections - drug therapy | Longitudinal Studies | Cohort analysis | Usage | Demographic aspects | Comorbidity | Distribution | Reports | Hepatitis C | HIV infection | Antiretroviral drugs | Liver diseases | Disease | Physicians | Mortality | Hepatitis | Liver cancer | Hospitals | Human immunodeficiency virus--HIV | Data collection | Behavior | Clinical medicine | Liver cirrhosis | Life Sciences | Human health and pathology | Infectious diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients
by Allavena, Clotilde and Hanf, Matthieu and Rey, David and Duvivier, Claudine and BaniSadr, Firouze and Poizot-Martin, Isabelle and Jacomet, Christine and Pugliese, Pascal and Delobel, Pierre and Katlama, Christine and Joly, Véronique and Chidiac, Christian and Dournon, Nathalie and Merrien, Dominique and May, Thierry and Reynes, Jacques and Gagneux-Brunon, Amandine and Chirouze, Catherine and Huleux, Thomas and Cabié, André and Raffi, François and DatAIDS Study Grp and Dat’AIDS study group and the Dat’AIDS study group
PLoS ONE, ISSN 1932-6203, 09/2018, Volume 13, Issue 9, p. e0203895
As HIV-infected adults on successful antiretroviral therapy (ART) are expected to have close to normal lifespans, they will increasingly develop age-related... 
INDIVIDUALS | THERAPY | MEDICATIONS | AGE-RELATED COMORBIDITIES | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | HIV-1-INFECTED PATIENTS | RENAL-DISEASE | COHORT | PREVALENCE | COMBINATION | Antiviral agents | Comorbidity | Aged patients | Dosage and administration | Research | Drug therapy | Health aspects | HIV infection | Elderly people | Therapy | Dyslipidemia | Infections | Thymidine | Medical diagnosis | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Older people | Human immunodeficiency virus--HIV | Aging | Population | Age | Antiretroviral drugs | Life expectancy | Mortality | Proteinase inhibitors | Antiretroviral therapy | CD4 antigen | Infectious diseases | Hospitals | Protease inhibitors | Adults | Elderly | Geriatrics | Life Sciences | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text “Real life” use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study
by Gantner, Pierre and Sylla, Babacar and Morand-Joubert, Laurence and Frange, Pierre and Lacombe, Karine and Khuong, Marie-Aude and Duvivier, Claudine and Launay, Odile and Karmochkine, Marina and Arvieux, Cédric and Ménard, Amélie and Piroth, Lionel and Canestri, Ana and Trias, Dominique and Peytavin, Gilles and Landman, Roland and Ghosn, Jade and on behalf of the Coferal-IMEA048 Study Group
PLOS ONE, ISSN 1932-6203, 04/2019, Volume 14, Issue 4, p. e0216010
Introduction Limited “real life” data on raltegravir (RAL) use during pregnancy are available. Thus, we aimed at describing effectiveness and safety of... 
Antiretroviral drugs | Demography | Gestation | Ribonucleic acid--RNA | Medical diagnosis | Antiretroviral therapy | Pregnancy | Demographics | Disease transmission | Acquired immune deficiency syndrome--AIDS | Womens health | Antiretroviral agents | Human immunodeficiency virus--HIV | Safety | Life Sciences | Human health and pathology | Pharmacology | Infectious diseases | Pharmaceutical sciences | RNA | Ribonucleic acid | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text "Real life" use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study
by Gantner, P and Sylla, B and Morand-Joubert, L and Frange, P and Lacombe, K and Khuong, MA and Duvivier, C and Launay, O and Karmochkine, M and Arvieux, C and Menard, A and Piroth, L and Canestri, A and Trias, D and Peytavin, G and Landman, R and Ghosn, J and Benalycharif, A and Amat, K and Girard, PM and Yazdanpanah, Y and Lortholary, O and Pialoux, G and Weiss, L and Michelet, C and Stein, A and Coferal-IMEA048 Study Grp and Coferal-IMEA048 Study Group
PLOS ONE, ISSN 1932-6203, 04/2019, Volume 14, Issue 4, pp. e0216010 - e0216010
Introduction Limited "real life" data on raltegravir (RAL) use during pregnancy are available. Thus, we aimed at describing effectiveness and safety of... 
WOMEN | TRANSMISSION | THERAPY | HIV | PHARMACOKINETICS | SAFETY | MULTIDISCIPLINARY SCIENCES | EFAVIRENZ | INHIBITORS | RITONAVIR | DELIVERY | Complications and side effects | Pregnant women | Physiological aspects | Dosage and administration | Research | Drug therapy | Raltegravir
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients
by Duvivier, Claudine and Kolta, Sami and Assoumou, Lambert and Ghosn, Jade and Rozenberg, Sylvie and Murphy, Robert L and Katlama, Christine and Costagliola, Dominique and ANRS 121 Hippocampe Study Grp and ANRS 121 Hippocampe study group
AIDS, ISSN 0269-9370, 04/2009, Volume 23, Issue 7, pp. 817 - 824
Objective: To evaluate the change in bone mineral density (BMD) at specific sites in patients initiating antiretroviral therapy in a substudy of the ANRS 121... 
Osteoporosis | HIV | Protease inhibitors | Bone mineral density | Nonnucleoside reverse transcriptase inhibitors | Antiretroviral therapy | Osteopenia | osteopenia | INFECTIOUS DISEASES | antiretroviral therapy | B LIGAND RANKL | IMMUNOLOGY | osteoporosis | HUMAN-IMMUNODEFICIENCY-VIRUS | nonnucleoside reverse transcriptase inhibitors | HIV-INFECTED PATIENTS | INDIVIDUALS | bone mineral density | WOMEN | VIROLOGY | ACTIVE ANTIRETROVIRAL THERAPY | MEN | protease inhibitors | MASS-LOSS | HIV Protease Inhibitors - adverse effects | HIV-1 | Bone Density - physiology | Drug Administration Schedule | Humans | Middle Aged | Male | CD4 Lymphocyte Count | Lumbar Vertebrae - drug effects | Bone Diseases, Metabolic - chemically induced | Viral Load | Reverse Transcriptase Inhibitors - adverse effects | Bone Density - drug effects | Adult | Female | HIV Infections - drug therapy | Bone Diseases, Metabolic - physiopathology | Lumbar Vertebrae - physiopathology | Index Medicus | AIDS/HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy
by Piketty, Christophe and Selinger-Leneman, Hana and Grabar, Sophie and Duvivier, Claudine and Bonmarchand, Manuela and Abramowitz, Laurent and Costagliola, Dominique and Mary-Krause, Murielle and FHDH ANRS CO 4 and FHDH-ANRS CO 4
AIDS, ISSN 0269-9370, 06/2008, Volume 22, Issue 10, pp. 1203 - 1211
Objective: To describe the cases of anal cancer that appeared in the French Hospital Database on HIV between 1992 and 2004 and to study risk factors of anal... 
Papillomavirus | Immune restoration | Combination antiretroviral therapy | Human papillomavirus infection | Anal cancer | HIV infection | Cancer | ACQUIRED-IMMUNODEFICIENCY-SYNDROME | UNITED-STATES | INFECTIOUS DISEASES | SQUAMOUS INTRAEPITHELIAL LESIONS | POSITIVE PATIENTS | papillomavirus | IMMUNOLOGY | anal cancer | CELL CARCINOMA | human papillomavirus infection | VIROLOGY | ERA | MEN | cancer | AIDS-DEFINING CANCERS | combination antiretroviral therapy | HIGH PREVALENCE | immune restoration | HUMAN-PAPILLOMAVIRUS INFECTION | France - epidemiology | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Incidence | Anus Neoplasms - complications | Anus Neoplasms - mortality | HIV Infections - complications | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - mortality | Drug Therapy, Combination | Homosexuality, Male - statistics & numerical data
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Detectable HIV-RNA in semen of HIV controllers
by Chaix, Marie-Laure and Boufassa, Faroudy and Meyzer, Candice and Leruez-Ville, Marianne and Mahjoub, Nadia and Nere, Marie-Laure and Genet, Philippe and Duvivier, Claudine and Lascoux-Combes, Caroline and Lambotte, Olivier and Ghosn, Jade
PLoS ONE, ISSN 1932-6203, 08/2017, Volume 12, Issue 8, p. e0183376
Background Whether spontaneous low levels of HIV-1 RNA in blood plasma correlate with low levels of HIV-1 RNA in seminal plasma has never been investigated in... 
CELLS | SUCCESSFUL ANTIRETROVIRAL REGIMENS | THERAPY | PLASMA | MULTIDISCIPLINARY SCIENCES | SEX | INFECTED MEN | BLOOD | HIV Infections - blood | Humans | Middle Aged | Semen - chemistry | Male | RNA, Viral - blood | Young Adult | Adolescent | Polymerase Chain Reaction | Adult | RNA, Viral - metabolism | Child | HIV Infections - metabolism | Measurement | Semen | Viremia | Genotype | Genetic aspects | HIV (Viruses) | Comparative analysis | Health aspects | Blood plasma | Testing | Plasma | Shedding | Antiretroviral drugs | Health risks | Leukocytes (mononuclear) | Ribonucleic acid--RNA | Blood | Polymerase chain reaction | Acquired immune deficiency syndrome--AIDS | Correlation analysis | Human immunodeficiency virus--HIV | Men | Peripheral blood mononuclear cells | Drug therapy | Deoxyribonucleic acid--DNA | Viral infections | Life Sciences | Microbiology and Parasitology | Santé publique et épidémiologie | Virology | RNA | Ribonucleic acid | AIDS | HIV | Acquired immune deficiency syndrome | Deoxyribonucleic acid | DNA | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Identification of variants of hepatitis C virus (HCV) entry factors in patients highly exposed to HCV but remaining uninfected: An ANRS case-control study
by Fouquet, Baptiste and Ghosn, Jade and Quertainmont, Yann and Salmon, Dominique and Rioux, Christophe and Duvivier, Claudine and Delfraissy, Jean-François and Misrahi, Micheline
PLoS ONE, ISSN 1932-6203, 11/2015, Volume 10, Issue 11, p. e0142698
Hepatitis C virus (HCV) causes persistent infection in 75% of cases and is a major public health problem worldwide. More than 92% of intravenous drug users... 
POLYMORPHISMS | GENE | INTRAVENOUS-DRUG-USERS | HOST FACTORS | MULTIDISCIPLINARY SCIENCES | SUSCEPTIBILITY | RESISTANCE | AIDS | HIV-1 INFECTION | CCR5 VARIANTS | DISEASE PROGRESSION | Claudins - genetics | HIV Infections - virology | Humans | Middle Aged | Computational Biology | Hepatitis C - genetics | Male | Scavenger Receptors, Class B - genetics | Substance Abuse, Intravenous | DNA Primers | Drug Users | Sequence Analysis, DNA | Case-Control Studies | Occludin - genetics | HIV Infections - complications | Adult | Female | Heterozygote | Mutation | Disease Resistance - genetics | Hepacivirus | Hepatitis C - transmission | Care and treatment | Patient outcomes | Physiological aspects | Development and progression | Genetic aspects | Research | Hepatitis C | Liver cells | Drug abuse | Intravenous administration | Viruses | Patients | Gene sequencing | Hepatitis | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Infectivity | Hepatitis C virus | Public health | Drug use | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Influence of lifelong cumulative HIV viremia on long-term recovery of CD4+ cell count and CD4+/CD8+ ratio among patients on combination antiretroviral therapy
by Seng, Rémonie and Goujard, Cécile and Krastinova, Evguenia and Miailhes, Patrick and Orr, Sylvie and Molina, Jean-Michel and Saada, Matthieu and Piroth, Lionel and Rouzioux, Christine and Meyer, Laurence and ANRS PRIMO Cohort
AIDS, ISSN 0269-9370, 03/2015, Volume 29, Issue 5, pp. 595 - 607
OBJECTIVE:We explored the impact of lifelong cumulative HIV viremia on immunological recovery during antiretroviral therapy, according to the timing of... 
CD4 | CD8 | primary HIV infection | HIV viremia | antiretroviral treatment | immune restoration | ratio | Anti-Retroviral Agents - therapeutic use | Prospective Studies | Humans | Male | CD4 Lymphocyte Count | Secondary Prevention | Viremia - drug therapy | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | CD4-CD8 Ratio | Medication Adherence | Time Factors | Adult | Female | HIV Infections - drug therapy | Antiretroviral Therapy, Highly Active - methods | CD8-Positive T-Lymphocytes - immunology | Longitudinal Studies | Cohort Studies
Journal Article